Liraglutide vs Semaglutide: Key Differences & Risks
What’s the difference between liraglutide vs semaglutide? This article breaks everything down.
- When comparing liraglutide vs semaglutide, both are GLP-1 receptor agonists that work similarly but differ in dosing schedules.
- Semaglutide is available as weekly injections or daily oral tablets, while liraglutide is available only as daily injections.
- Both medications have similar gastrointestinal side effects, including nausea, vomiting, upset stomach, diarrhea, constipation, and reduced appetite.
- No single medication is automatically better for everyone; the right choice depends on your individual health history, lifestyle preferences, and your healthcare provider’s recommendations.
- Both liraglutide and semaglutide require a prescription and should only be started, stopped, or switched under the guidance of a licensed healthcare professional.
The following is not intended as medical advice or treatment. It’s always essential to discuss your options with your doctor; they know you and your health status and situation the best and can offer personalized advice tailored to you and your situation.
How Does Semaglutide Differ From Liraglutide?
Semaglutide and liraglutide are both GLP-1 receptor agonists. But this doesn’t mean they’re identical. While they may yield similar outcomes, they differ in dosing schedules, formulations, potencies, and tolerability.
Due to these differences, it’s always important to discuss what’s right for you with your licensed healthcare provider. They know you and your health situation best and can offer personalized guidance.
For more info about the exact differences between liraglutide vs semaglutide, keep reading below.
{{primary-cta}}
What is Semaglutide?
Semaglutide is best known under the three brand names: Ozempic®, Wegovy®, and Rybelsus®. It’s available in two prescription forms, as either an injectable or oral pill.
With the injected format (Ozempic® or Wegovy®), it’s usually taken once a week. Meanwhile, the oral pill (Rybelsus®) is taken once daily, with a bit of water. After taking the pill form, it’s advised to wait at least 30 minutes before eating or drinking.
Like other GLP-1 receptor agonists, semaglutide stimulates the GLP-1 receptor, which plays a role in blood sugar regulation and appetite signaling.
Here’s a quick breakdown of what each brand name has been FDA-approved for:
- Ozempic®: Approved for type 2 diabetes to improve glycemic control and to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular diseases.
- Wegovy®: Approved for chronic weight management, as an adjunct to a reduced-calorie diet and increased physical activity, in adults and certain adolescents with obesity (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) with at least one weight-related condition (such as hypertension, type 2 diabetes, or dyslipidemia), as described in the FDA-approved prescribing information.
- Rybelsus®: Approved for adults with type 2 diabetes to improve glycemic control.
All forms of semaglutide must be prescribed by a licensed healthcare provider, who can determine whether it’s appropriate based on your current health status and medical history.
What is Liraglutide?
Liraglutide (sold under the brand names Victoza® and Saxenda®) is another GLP-1 receptor agonist, but it differs from semaglutide in a few ways, including:
- It’s taken once daily; there is no weekly option.
- It has a shorter duration of action, which is why it must be injected daily.
- It’s only available as an injectable.
Victoza® is FDA-approved for adults and pediatric patients ages 10 or over with type 2 diabetes. Saxenda®, on the other hand, is FDA-approved for chronic weight management for adults meeting specific BMI criteria and some adolescents.
In particular, liraglutide may offer some individuals more flexibility with daily dosing. However, this can vary from person to person. It may also come down to what you, individually, tolerate better.
Which is Safer, Liraglutide or Semaglutide?
At the end of the day, liraglutide and semaglutide both come with risks, contraindications, and side effects. Which one is safer or more appropriate depends on the individual, including your medical history, other medications, and how you respond to treatment.
Semaglutide Side Effects
Semaglutide’s most common side effects involve gastrointestinal symptoms, especially when first starting this medication. These may include:
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Stomach discomfort
- Decreased appetite
On the other hand, less common side effects may include pancreatitis, kidney issues, or gallbladder problems. If any abnormal or severe symptoms arise, it’s essential to seek out immediate medical attention.
Liraglutide Side Effects
While side effects vary from person to person, liraglutide has similar side effects to semaglutide, such as:
- Nausea
- Constipation
- Vomiting
- Abdominal discomfort
- Diarrhea
- Reduced appetite
Severe, but less common, side effects are also similar to semaglutide. Ultimately, your doctor will determine which is the safer option for you.
{{primary-cta}}
Liraglutide vs Semaglutide: A Side-By-Side Comparison
Final Thoughts
While either liraglutide or semaglutide can be an effective option, the right choice depends on your health history and your doctor’s recommendations. They have similar mechanisms of action, but slight differences may make one more suitable for you and your situation.
As always, never stop or start any medication without proper guidance from a licensed healthcare practitioner.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by state-licensed pharmacies. Please consult a licensed healthcare provider before making any medical decisions.
Frequently asked questions
Yes, many people transition between these medications. But doing so should only be done under the guidance and supervision of a qualified medical practitioner.
Liraglutide is not recommended for individuals with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). It’s also not recommended if you’re pregnant or have any allergies to liraglutide’s ingredients.
When comparing metformin vs semaglutide, there are a few things to note. First, metformin is a first-line medication for type 2 diabetes. It’s taken orally and works by improving insulin sensitivity and reducing the amount of glucose produced by the liver. In contrast, semaglutide may be added as an additional support to help further manage blood sugar and appetite signaling.
While both medications are GLP-1 receptor agonists, semaglutide has a longer half-life and comes in daily oral pills or weekly injectables. Dulaglutide is a once-weekly injectable. Your healthcare provider can help you determine which is best for you.
While there is no set timeline, regular follow-ups and monitoring with your healthcare provider ensure that semaglutide is proving useful and not harmful to your health goals.
Blog Components

References
Kommu, S., & Whitfield, P. (2024). Semaglutide. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK603723/
WEGOVY. (2017). WEGOVY (semaglutide) injection, for subcutaneous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
OZEMPIC. (2023). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf
Novo Nordisk Inc. (2017). RYBELSUS® (semaglutide) tablets, for oral use. https://www.novo-pi.com/rybelsus.pdf
Novo Nordisk Inc. (2010). VICTOZA. https://www.novo-pi.com/victoza.pdf#guide
Novo Nordisk Inc. (2010). SAXENDA. https://www.novo-pi.com/saxenda.pdf#guide
The wellness insight you need, without the noise.


















